Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
Neuroimage. Clinical|September 1, 2021
Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase studyMichael Barnett, Niels Bergsland, Bianca Weinstock-Guttman, et al.
Arquivos De Neuro-Psiquiatria|February 23, 2022
Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depressionSerhan Sevim, Meltem Demirkiran, Murat Terzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 23, 2023
The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosisCavit Boz, Serkan Ozakbas, Murat Terzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2025
Disease course after pregnancy in women with progressive multiple sclerosis symptomsJessica Shipley, Heidi N Beadnall, Paul G Sanfilippo, et al.
Neurology|March 11, 2014
Fingolimod after natalizumab and the risk of short-term relapseVilija G Jokubaitis, Vivien Li, Tomas Kalincik, et al.
Multiple Sclerosis and Related Disorders|September 2, 2019
Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosisCavit Boz, Murat Terzi, Bilge Özer, et al.
The Neurologist|October 16, 2015
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory FeaturesAyse Altintas, Rana Karabudak, Belgin P Balci, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2018
Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosisMyintzu Min, Tim Spelman, Alessandra Lugaresi, et al.
JAMA Neurology|July 28, 2020
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple SclerosisNathaniel Lizak, Charles B Malpas, Sifat Sharmin, et al.
Neurology|March 6, 2024
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based StudyTim Spelman, Gabrielle Simoneau, Robert Hyde, et al.
Pageof 16